Systematic Review: Urine Biomarker Discovery for Inflammatory Bowel Disease Diagnosis

Inflammatory bowel diseases (IBDs) are chronic, heterogeneous, and inflammatory conditions mainly affecting the gastrointestinal tract. Currently, endoscopy is the gold standard test for assessing mucosal activity and healing in clinical practice; however, it is a costly, time-consuming, invasive, a...

Full description

Bibliographic Details
Main Authors: Montse Baldan-Martin, María Chaparro, Javier P. Gisbert
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/12/10159
_version_ 1797594285638418432
author Montse Baldan-Martin
María Chaparro
Javier P. Gisbert
author_facet Montse Baldan-Martin
María Chaparro
Javier P. Gisbert
author_sort Montse Baldan-Martin
collection DOAJ
description Inflammatory bowel diseases (IBDs) are chronic, heterogeneous, and inflammatory conditions mainly affecting the gastrointestinal tract. Currently, endoscopy is the gold standard test for assessing mucosal activity and healing in clinical practice; however, it is a costly, time-consuming, invasive, and uncomfortable procedure for the patients. Therefore, there is an urgent need for sensitive, specific, fast and non-invasive biomarkers for the diagnosis of IBD in medical research. Urine is an excellent biofluid for discovering biomarkers because it is non-invasive to sample. In this review, we aimed to summarize proteomics and metabolomics studies performed in both animal models of IBD and humans that identify urinary biomarkers for IBD diagnosis. Future large-scale multi-omics studies should be conducted in collaboration with clinicians, researchers, and industry to make progress toward the development of sensitive and specific diagnostic biomarkers, thereby making personalized medicine possible.
first_indexed 2024-03-11T02:21:30Z
format Article
id doaj.art-8a26f882d57e4cbb9a9c76b4589259a5
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T02:21:30Z
publishDate 2023-06-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-8a26f882d57e4cbb9a9c76b4589259a52023-11-18T10:49:31ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-06-0124121015910.3390/ijms241210159Systematic Review: Urine Biomarker Discovery for Inflammatory Bowel Disease DiagnosisMontse Baldan-Martin0María Chaparro1Javier P. Gisbert2Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Universidad Autónoma de Madrid, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), 28006 Madrid, SpainGastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Universidad Autónoma de Madrid, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), 28006 Madrid, SpainGastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Universidad Autónoma de Madrid, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), 28006 Madrid, SpainInflammatory bowel diseases (IBDs) are chronic, heterogeneous, and inflammatory conditions mainly affecting the gastrointestinal tract. Currently, endoscopy is the gold standard test for assessing mucosal activity and healing in clinical practice; however, it is a costly, time-consuming, invasive, and uncomfortable procedure for the patients. Therefore, there is an urgent need for sensitive, specific, fast and non-invasive biomarkers for the diagnosis of IBD in medical research. Urine is an excellent biofluid for discovering biomarkers because it is non-invasive to sample. In this review, we aimed to summarize proteomics and metabolomics studies performed in both animal models of IBD and humans that identify urinary biomarkers for IBD diagnosis. Future large-scale multi-omics studies should be conducted in collaboration with clinicians, researchers, and industry to make progress toward the development of sensitive and specific diagnostic biomarkers, thereby making personalized medicine possible.https://www.mdpi.com/1422-0067/24/12/10159inflammatory bowel diseaseCrohn’s diseaseulcerative colitisbiomarkersurineproteomics
spellingShingle Montse Baldan-Martin
María Chaparro
Javier P. Gisbert
Systematic Review: Urine Biomarker Discovery for Inflammatory Bowel Disease Diagnosis
International Journal of Molecular Sciences
inflammatory bowel disease
Crohn’s disease
ulcerative colitis
biomarkers
urine
proteomics
title Systematic Review: Urine Biomarker Discovery for Inflammatory Bowel Disease Diagnosis
title_full Systematic Review: Urine Biomarker Discovery for Inflammatory Bowel Disease Diagnosis
title_fullStr Systematic Review: Urine Biomarker Discovery for Inflammatory Bowel Disease Diagnosis
title_full_unstemmed Systematic Review: Urine Biomarker Discovery for Inflammatory Bowel Disease Diagnosis
title_short Systematic Review: Urine Biomarker Discovery for Inflammatory Bowel Disease Diagnosis
title_sort systematic review urine biomarker discovery for inflammatory bowel disease diagnosis
topic inflammatory bowel disease
Crohn’s disease
ulcerative colitis
biomarkers
urine
proteomics
url https://www.mdpi.com/1422-0067/24/12/10159
work_keys_str_mv AT montsebaldanmartin systematicreviewurinebiomarkerdiscoveryforinflammatoryboweldiseasediagnosis
AT mariachaparro systematicreviewurinebiomarkerdiscoveryforinflammatoryboweldiseasediagnosis
AT javierpgisbert systematicreviewurinebiomarkerdiscoveryforinflammatoryboweldiseasediagnosis